Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 4 subfamily F member 32, pseudogene (CYP4F32P) is a human pseudogene that belongs to the large cytochrome P450 gene superfamily. Unlike other functional members of the family—which encode enzymes involved in fatty acid metabolism, cholesterol synthesis, and drug metabolism—CYP4F32P does not produce a functional protein. As such, it has no established role in biological pathways, disease mechanisms, or pharmacology[1][4]. Key facts: - CYP4F32P is not a functional enzyme or receptor. - It is classified strictly as a pseudogene: a DNA sequence similar to a functional gene but which does not result in a protein product and has no known function[1][4]. - There is no evidence it acts as a drug target, biomarker, or has a clinical role. Summary judgment: CYP4F32P is not a valid therapeutic target, contains no functionally relevant biological or disease associations, and does not interact with drugs. Any listing or suggestion as a functional target is incorrect based on current gene annotation databases and expert consensus[1][4].
None (not a functional protein, so not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 32, pseudogene (CYP4F32P).